BI 690517, Jardiance 10 mg film-coated tablets, Placebo matching vicadrostat
1378-0023
Phase 2 small_molecule active
Quick answer
BI 690517, Jardiance 10 mg film-coated tablets, Placebo matching vicadrostat for chronic kidney disease is a Phase 2 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- chronic kidney disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active